CPMV (Mosaic ImmunoEngineering) Accounts Payable: $0.17 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mosaic ImmunoEngineering Accounts Payable?

Mosaic ImmunoEngineering CPMV +11.11% Accounts Payable is $0.17 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Mosaic ImmunoEngineering's Accounts Payable for the quarter that ended in Mar. 2026 was $0.17 Mil.

Mosaic ImmunoEngineering's quarterly Accounts Payable declined from Sep. 2025 ($0.13 Mil) to Dec. 2025 ($0.13 Mil) but then increased from Dec. 2025 ($0.13 Mil) to Mar. 2026 ($0.17 Mil).

Mosaic ImmunoEngineering's annual Accounts Payable increased from Dec. 2023 ($0.12 Mil) to Dec. 2024 ($0.14 Mil) but then declined from Dec. 2024 ($0.14 Mil) to Dec. 2025 ($0.13 Mil).

Mosaic ImmunoEngineering Accounts Payable Related Terms

Mosaic ImmunoEngineering Accounts Payable Historical Data

* Premium members only.

The historical data trend for Mosaic ImmunoEngineering's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mosaic ImmunoEngineering Accounts Payable Chart

Mosaic ImmunoEngineering Annual Data
Trend May16 May17 May18 May19 May20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.13 0.12 0.14 0.13

Mosaic ImmunoEngineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.13 0.13 0.13 0.17

Mosaic ImmunoEngineering Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.17 Mil mean?
Mosaic ImmunoEngineering (CPMV) has a Accounts Payable of $0.17 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Mosaic ImmunoEngineering and its competitors.
Is Mosaic ImmunoEngineering's Accounts Payable too high?
Mosaic ImmunoEngineering's current Accounts Payable is $0.17 Mil.
How does Mosaic ImmunoEngineering's Accounts Payable compare to TCRT and JAGX?
Mosaic ImmunoEngineering's Accounts Payable of $0.17 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Mosaic ImmunoEngineering and its competitors. Mosaic ImmunoEngineering's current Accounts Payable is $0.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mosaic ImmunoEngineering stock overvalued right now?
Mosaic ImmunoEngineering (CPMV) has a current Accounts Payable of $0.17 Mil. The current Accounts Payable is $0.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Mosaic ImmunoEngineering (CPMV), the current Accounts Payable is $0.17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mosaic ImmunoEngineering Business Description

Address 9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646
Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions. The company is pursuing new product candidates and platforms to build a product pipeline based on its deep understanding of immunotherapies.